GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
1-Year Return
49.13%
This Quarter Return
+7.52%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$357M
AUM Growth
-$45.9M
(-11%)
Cap. Flow
+$1.9M
Cap. Flow
% of AUM
0.53%
Top 10 Holdings %
Top 10 Hldgs %
48.05%
Holding
58
New
14
Increased
10
Reduced
11
Closed
8
Top Buys
| 1 |
Kura Oncology
KURA
|
$7.77M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$6.63M |
| 3 |
Celldex Therapeutics
CLDX
|
$5.15M |
| 4 |
ESSA Pharma
EPIX
|
$5.08M |
| 5 |
Gyre Therapeutics
GYRE
|
$5.04M |
Top Sells
| 1 |
Travere Therapeutics
TVTX
|
$12.9M |
| 2 |
SURF
Surface Oncology, Inc. Common Stock
SURF
|
$9.24M |
| 3 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$8.51M |
| 4 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$8.19M |
| 5 |
Rocket Pharmaceuticals
RCKT
|
$7.76M |
Sector Composition
| 1 | Healthcare | 92.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
BioCryst Pharmaceuticals
BCRX
$1.74B
| $5.09M | 1.2% |
500,000
-400,000
| -44% | -$4.07M |
|
|
27
ESSA Pharma
EPIX
$11M
| $5.08M | 1.19% |
+175,000
| New | +$5.08M |
|
|
28
Gyre Therapeutics
GYRE
$688M
| $5.04M | 1.18% |
+133,333
| New | +$5.04M |
|
29
Viridian Therapeutics
VRDN
$1.52B
| $5.01M | 1.18% |
+300,000
| New | +$5.01M |
|
30
Nuvation Bio
NUVB
$1.17B
| $4.96M | 1.17% |
+500,000
| New | +$4.96M |
|
31
Curis
CRIS
$21.4M
| $4.81M | 1.13% |
21,250
| – | – |
|
|
BCYC
32
Bicycle Therapeutics
BCYC
$483M
| $4.48M | 1.05% |
+150,000
| New | +$4.48M |
|
33
FibroGen
FGEN
$45.7M
| $4.34M | 1.02% |
+5,000
| New | +$4.34M |
|
34
Immunic
IMUX
$76M
| $4.22M | 0.99% |
265,000
| – | – |
|
35
Immunovant
IMVT
$2.81B
| $4.01M | 0.94% |
250,000
-50,000
| -17% | -$802K |
|
|
SRRA
36
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $3.45M | 0.81% |
200,000
| – | – |
|
37
Novavax
NVAX
$1.27B
| $3.17M | 0.75% |
+17,500
| New | +$3.17M |
|
38
Amicus Therapeutics
FOLD
$2.47B
| $2.62M | 0.62% |
265,000
-335,000
| -56% | -$3.31M |
|
|
KDMN
39
DELISTED
Kadmon Holdings, Inc.
KDMN
| $2.33M | 0.55% |
+600,000
| New | +$2.33M |
|
|
SAGE
40
DELISTED
Sage Therapeutics
SAGE
| $2.25M | 0.53% |
+30,000
| New | +$2.25M |
|
|
CTIC
41
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $2.18M | 0.51% |
750,000
| – | – |
|
42
Precision BioSciences
DTIL
$59.3M
| $2.07M | 0.49% |
+6,667
| New | +$2.07M |
|
|
CMRX
43
DELISTED
Chimerix, Inc.
CMRX
| $1.93M | 0.45% |
+200,000
| New | +$1.93M |
|
44
CASI Pharmaceuticals
CASI
$35.3M
| $1.56M | 0.37% |
+65,000
| New | +$1.56M |
|
45
Aptevo Therapeutics
APVO
$5.36M
| $1.53M | 0.36% |
2
| – | – |
|
|
OTIC
46
DELISTED
Otonomy, Inc.
OTIC
| $1.15M | 0.27% |
450,000
+250,000
| +125% | +$638K |
|
|
AMRN
47
Amarin Corp
AMRN
$311M
| – | – |
-20,000
| Closed | -$1.96M |
|
48
ARK Genomic Revolution ETF
ARKG
$1.05B
| – | – |
0
| – | – |
|
49
KalVista Pharmaceuticals
KALV
$765M
| – | – |
-200,000
| Closed | -$3.8M |
|
50
Korro Bio
KRRO
$264M
| – | – |
0
| – | – |
|